Medindia

X

Radiation Therapy Could Be An Attractive Option In Managing Rare Pancreatic Cancer

by Aruna on  November 24, 2009 at 10:00 AM Cancer News   - G J E 4
Radiation Therapy Could Be An Attractive Option In Managing Rare Pancreatic Cancer
A study says that people with rare pancreatic cancer, called pancreatic neuroendocrine tumors (PNTs), might live longer if treated with radiation therapy.
Advertisement

The researchers found that this method is effective in achieving local control and palliation in PNTs, despite such tumors being commonly considered resistant to radiation therapy.

Advertisement
PNT is a very rare form of pancreatic cancer that can stay confined to the liver and often cause death from liver damage.

As it is usually unable to be removed by surgery, external beam radiation therapy (EBRT) is an attractive option for managing the disease.

However, the role of EBRT is largely unknown because of the low incidence of this tumor type and, as a result, very few related studies.

Researchers at the departments of radiation oncology and internal medicine, division of hematology/oncology and comprehensive cancer center biostatistics unit at the University of Michigan in Ann Arbor, Mich., wanted to determine if PNTs are not as resistant to radiation therapy as was previously thought.

Thus, they reviewed records from 36 patients with PNTs who were treated between 1986 and 2006 with radiation therapy to 49 sites.

And the researchers found that in 39 percent of patients the tumor shrunk to less than half its pretreatment size after being treated with EBRT.

Also, radiation therapy treatments achieved high rates of local control and 90 percent of patients experienced palliation of symptoms such as pain, nausea, vomiting or obstructive jaundice.

"While this particular type of cancer can have potentially devastating effects on a patient, this study proves that using external beam radiation therapy may permit these patients to live longer, which is a very positive breakthrough for a disease that can have very negative outcomes," said Dr. Theodore S. Lawrence, an author on the study.

The study is published in the latest issue of the International Journal of Radiation Oncology.

Source: ANI
ARU
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All